本文選題：維吾爾藥 + 藥性　； 參考：《中國(guó)藥理學(xué)與毒理學(xué)雜志》2017年06期

【摘要】：維吾爾醫(yī)藥學(xué)是我國(guó)民族醫(yī)藥學(xué)的一個(gè)重要組成部分,是現(xiàn)代醫(yī)藥的重要補(bǔ)充。近年來(lái),隨著現(xiàn)代科學(xué)的發(fā)展,維吾爾藥的現(xiàn)代基礎(chǔ)和應(yīng)用研究取得了諸多進(jìn)展。維醫(yī)根據(jù)維吾爾藥藥性,將藥物分為熱性藥、濕性藥、寒性藥、干性藥、干熱性藥、濕熱性藥、濕寒性藥和干寒性藥。根據(jù)藥性的強(qiáng)弱分為4級(jí),藥性三級(jí)或四級(jí)的大多數(shù)藥物被認(rèn)為具有毒性。本文主要對(duì)中華人民共和國(guó)原衛(wèi)生部頒發(fā)藥品標(biāo)準(zhǔn)——維吾爾藥分冊(cè)(1998年)收錄的三級(jí)和四級(jí)藥材的藥性與毒性進(jìn)行概述。
[Abstract]:Uygur medicine is an important part of national medicine and an important supplement of modern medicine. In recent years, with the development of modern science, many progress has been made in the research of Uygur medicine. According to Uygur medicine, Uygur medicine can be divided into hot medicine, wet medicine, cold medicine, dry medicine, dry heat medicine, damp heat medicine, wet cold medicine and dry cold medicine. Most drugs in three or four levels are considered toxic, depending on the strength of the drug. In this paper, the medicinal properties and toxicity of three and four kinds of medicinal materials issued by the former Ministry of Health of the people's Republic of China-Uygur Medicine Division (1998) are summarized.
【作者單位】： 新疆維吾爾自治區(qū)藥物研究所;國(guó)家食品藥品監(jiān)督管理局藥品審評(píng)中心;
【基金】：新疆維吾爾自治區(qū)自然科學(xué)基金青年基金項(xiàng)目(2016D01B056) 新疆地產(chǎn)中藥民族藥新藥研發(fā)項(xiàng)目(2017-01-03)~~
【分類(lèi)號(hào)】：R29

【相似文獻(xiàn)】

相關(guān)會(huì)議論文 前1條

1 李曉瑾;賈曉光;王平山;;關(guān)于新疆維吾爾藥產(chǎn)業(yè)發(fā)展的規(guī)劃意見(jiàn)[A];中華中醫(yī)藥學(xué)會(huì)第九屆中藥鑒定學(xué)術(shù)會(huì)議論文集——祝賀中華中醫(yī)藥學(xué)會(huì)中藥鑒定分會(huì)成立二十周年[C];2008年

，

本文編號(hào)：1791385